These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32908235)

  • 21. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
    Bartlett DW; Davis ME
    Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. siRNA function in RNAi: a chemical modification analysis.
    Chiu YL; Rana TM
    RNA; 2003 Sep; 9(9):1034-48. PubMed ID: 12923253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Sugar 2',4'-Modifications on Gene Silencing Activity of siRNA Duplexes.
    Malek-Adamian E; Fakhoury J; Arnold AE; Martínez-Montero S; Shoichet MS; Damha MJ
    Nucleic Acid Ther; 2019 Aug; 29(4):187-194. PubMed ID: 31084536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemical modification of siRNAs to improve serum stability without loss of efficacy.
    Choung S; Kim YJ; Kim S; Park HO; Choi YC
    Biochem Biophys Res Commun; 2006 Apr; 342(3):919-27. PubMed ID: 16598842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Phosphorothioate Chirality on Double-Stranded siRNAs: A Systematic Evaluation of Stereopure siRNA Designs.
    Sakamuri S; Eltepu L; Liu D; Lam S; Meade BR; Liu B; Dello Iacono G; Kabakibi A; Luukkonen L; Leedom T; Foster M; Bradshaw CW
    Chembiochem; 2020 May; 21(9):1304-1308. PubMed ID: 31863714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA major groove modifications improve siRNA stability and biological activity.
    Terrazas M; Kool ET
    Nucleic Acids Res; 2009 Feb; 37(2):346-53. PubMed ID: 19042976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and Biological Activity of Short Interfering RNAs Having Several Consecutive Amide Internucleoside Linkages.
    Kotikam V; Viel JA; Rozners E
    Chemistry; 2020 Jan; 26(3):685-690. PubMed ID: 31693228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune activation by siRNA/liposome complexes in mice is sequence- independent: lack of a role for Toll-like receptor 3 signaling.
    Kim JY; Choung S; Lee EJ; Kim YJ; Choi YC
    Mol Cells; 2007 Oct; 24(2):247-54. PubMed ID: 17978578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Influence of Modification with Phosphoryl Guanidine Combined with a 2'-O-Methyl or 2'-Fluoro Group on the Small-Interfering-RNA Effect.
    Pavlova AS; Yakovleva KI; Epanchitseva AV; Kupryushkin MS; Pyshnaya IA; Pyshnyi DV; Ryabchikova EI; Dovydenko IS
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of chemical modification on the potency, serum stability, and immunostimulatory properties of short shRNAs.
    Ge Q; Dallas A; Ilves H; Shorenstein J; Behlke MA; Johnston BH
    RNA; 2010 Jan; 16(1):118-30. PubMed ID: 19948766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA interference in mammalian cells by chemically-modified RNA.
    Braasch DA; Jensen S; Liu Y; Kaur K; Arar K; White MA; Corey DR
    Biochemistry; 2003 Jul; 42(26):7967-75. PubMed ID: 12834349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of a stabilized 177Lu-siRNA complex and evaluation of its stability and RNAi activity.
    Fathi M; Yavari K; Taghikhani M; Ghannadi Maragheh M
    Nucl Med Commun; 2015 Jun; 36(6):636-45. PubMed ID: 25759946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Designing dual-targeting siRNA duplexes having two active strands that combine siRNA and microRNA-like targeting.
    Sætrom P
    Methods Mol Biol; 2013; 942():169-77. PubMed ID: 23027051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving RNA interference in mammalian cells by 4'-thio-modified small interfering RNA (siRNA): effect on siRNA activity and nuclease stability when used in combination with 2'-O-alkyl modifications.
    Dande P; Prakash TP; Sioufi N; Gaus H; Jarres R; Berdeja A; Swayze EE; Griffey RH; Bhat B
    J Med Chem; 2006 Mar; 49(5):1624-34. PubMed ID: 16509579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural Studies and Gene Silencing Activity of siRNAs Containing Cationic Phosphoramidate Linkages.
    Vlaho D; Fakhoury JF; Damha MJ
    Nucleic Acid Ther; 2018 Feb; 28(1):34-43. PubMed ID: 29195060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent progress in chemically modified siRNAs.
    Gaglione M; Messere A
    Mini Rev Med Chem; 2010 Jun; 10(7):578-95. PubMed ID: 20500149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring directional invasion of serum nuclease into siRNA duplexes by asymmetrical terminal modifications.
    Huang Y; Ma Y; Guo Y; Zou L; Jin H; Zhong L; Wu Y; Zhang L; Yang Z
    ChemMedChem; 2014 Sep; 9(9):2111-9. PubMed ID: 25044832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, gene silencing, and molecular modeling studies of 4'-C-aminomethyl-2'-O-methyl modified small interfering RNAs.
    Gore KR; Nawale GN; Harikrishna S; Chittoor VG; Pandey SK; Höbartner C; Patankar S; Pradeepkumar PI
    J Org Chem; 2012 Apr; 77(7):3233-45. PubMed ID: 22372696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re-Engineering RNA Molecules into Therapeutic Agents.
    Egli M; Manoharan M
    Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recognition of siRNA asymmetry by TAR RNA binding protein.
    Gredell JA; Dittmer MJ; Wu M; Chan C; Walton SP
    Biochemistry; 2010 Apr; 49(14):3148-55. PubMed ID: 20184375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.